Treatment of Pregnant Women With OUD (SMART)

  • STATUS
    Recruiting
  • End date
    Jul 14, 2023
  • participants needed
    480
  • sponsor
    Yale University
Updated on 14 May 2022

Summary

The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)

Description

The investigators are proposing a cluster randomized clinical trial to compare the effectiveness of two models of support for reproductive health clinicians to provide care for pregnant and postpartum women with an OUD: 1) a collaborative care (CC) approach based upon the Massachusetts Office-Based-Opioid Treatment (OBOT) Model that would provide onsite training, and support to providers and participants through the use of care managers (CMs) vs 2) a telesupport approach modeled on the Project Extension for Community Healthcare Outcomes (ECHO), a remote education model that provides mentorship and guided practice and participation in a learning community, via video conferencing.

Details
Condition Opioid-use Disorder
Treatment Collaborative Care (CC), Extension for Community Healthcare Outcomes (ECHO)
Clinical Study IdentifierNCT04240392
SponsorYale University
Last Modified on14 May 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Provision of signed and dated informed consent form
Females age 18 or older
Documented pregnancy in the medical record at less than 34 weeks gestation
Delivery date no later than December 15, 2022
Willingness to adhere to the study schedule
Confirmed opioid use disorder by the DSM-5 Opioid Use Disorder questionnaire
Ability to communicate in English
No current plan to move out of the obstetrical provider treatment area within the study timeframe of approximately 44 weeks

Exclusion Criteria

Experiencing cognitive or emotional impairment that precludes the participant from providing informed consent
Current hospitalization, incarceration, or institutionalization (if women present for care after institutionalization, participation is possible
Current court case pending that would make incarceration likely during the study treatment period (approximately 44 weeks)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note